摘要
背景:术语酒精使用障碍(AUD)包含与经常使用酒精有关的不同疾病状态,并与相关的损害、残疾和未能在不同领域承担主要责任有关。许多神经递质系统都参与了酒精中毒的阶段或状态,从奖赏机制,与狂饮,到压力和焦虑,与复发和戒断有关。一些神经肽在焦虑和应激的控制中起着关键作用,并与酒精成瘾的病理机制建立密切的关系。其中,神经肽Y(NPY),促肾上腺皮质激素释放因子(CRF)/尿皮质激素和神经肽(NPS)的交叉对话,对大脑在疾病进展过程中出现的一些不适应过程负责。 方法:在本研究中,我们回顾文献主要关注这些神经肽在AUD的病理生理学中的参与,以及用于研究在配体结合后启动的信号机制以及与酒精上瘾相关的生物化学适应事件的拮抗剂的使用。也讨论了这些系统作为治疗目标以减轻或消除饮用乙醇所产生的危害的可能性。 结论:本文综述的多肽系统与其他神经递质系统以及它们的相互关系,都是对AUD治疗的目标。
关键词: 酒精使用障碍(AUD),酒精中毒,神经肽Y,皮质激素释放因子(CRF),神经肽S(NPS),尿皮质I,神经肽拮抗剂。
Current Medicinal Chemistry
Title:Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD)
Volume: 24 Issue: 23
关键词: 酒精使用障碍(AUD),酒精中毒,神经肽Y,皮质激素释放因子(CRF),神经肽S(NPS),尿皮质I,神经肽拮抗剂。
摘要: Background: The term Alcohol Use Disorder (AUD) incorporates different states of disease related to the recurrent use of alcohol and linked to the relevant impairment, disability and failure to perform major responsibilities in different realms. Many neurotransmitter systems are involved in the phases or states of alcoholism from reward mechanisms, associated to binge intoxication, to stress and anxiety linked to relapse and withdrawal. Some neuropeptides play a key function in the control of anxiety and stress, and establish a close relationship with the pathological mechanisms underlying alcohol addiction. Among them, Neuropeptide Y (NPY), Corticotropin-releasing factor (CRF)/Urocortins and Neuropeptide S (NPS) cross-talk, and are responsible for some of the maladaptation processes that the brain exhibits during the progression of the disease.
Method: In this study, we review the literature mainly focused on the participation of these neuropeptides in the pathophysiology of AUD, as well as on the use of antagonists designed to investigate signaling mechanisms initiated after ligand binding and their connection to biochemical adaptation events coupled to alcohol addiction. The possibility that these systems may serve as therapeutic objectives to mitigate or eliminate the harm that drinking ethanol generates, is also discussed. Conclusion: The peptide systems reviewed here, together with other neurotransmitter systems and their mutual relationships, are firm candidates to be targeted to treat AUD.Export Options
About this article
Cite this article as:
Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD), Current Medicinal Chemistry 2017; 24 (23) . https://dx.doi.org/10.2174/0929867324666170316120836
DOI https://dx.doi.org/10.2174/0929867324666170316120836 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prebiotic Carbohydrates for Therapeutics
Endocrine, Metabolic & Immune Disorders - Drug Targets Fetal Programming of the Human Brain: Is there a Link with Insurgence of Neurodegenerative Disorders in Adulthood?
Current Medicinal Chemistry Biosimilar Filgrastim in Autologous Peripheral Blood Hematopoietic Stem Cell Mobilization and Post-Transplant Hematologic Recovery
Current Medicinal Chemistry The Effects of Obesity on Drug Metabolism in Children
Drug Metabolism Letters DTCM-Glutarimide Hinders Growth of Childhood Leukemia Cells but Fails to Improve the Efficacy of Commonly Used Chemotherapeutic Agents
Current Bioactive Compounds Endogenous BMP-4/ROS/COX-2 Mediated IPC and Resveratrol Alleviated Brain Damage
Current Pharmaceutical Design Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines
Current Cardiology Reviews Application of Functional Genomics to Bronchial Asthma
Current Pharmacogenomics Antifungal Agents in Hematopoietic Stem Cell Transplantation
Current Pharmaceutical Design Specific Roles of NMDA Receptor Subunits in Mental Disorders
Current Molecular Medicine Imaging of Spinal Bone Tumors: Principles and Practice
Current Medical Imaging Recent Studies on the Antimicrobial Peptides Lactoferricin and Lactoferrampin
Current Molecular Medicine Recent Advances in Antifungal Agents
Mini-Reviews in Medicinal Chemistry The Endocrine Regulation of Stem Cells: Physiological Importance and Pharmacological Potentials for Cell-Based Therapy
Current Stem Cell Research & Therapy Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery
Current Nanoscience Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Therapeutic Potentials of Recently Identified PLD Inhibitors
Current Chemical Biology Topical Antimicrobials for Burn Wound Infections
Recent Patents on Anti-Infective Drug Discovery Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
Current Drug Delivery